Stereotactic Body Radiotherapy Dose Escalation in Pancreatic Cancer

Completed · Not applicable

Conditions studied: Pancreatic Cancer

In brief

This study is to determine the maximum tolerated dose (MTD) of five fraction stereotactic radiotherapy (SBRT) in pancreatic cancer.

Key facts

Study ID
NCT02454140
Run by
University of California, San Diego
People needed
30
Starts
2014-06-20
Expected to finish
2022-12-31
Last updated by the study team
2025-09-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.